Silo Pharma
(NASDAQ) SILO
Silo Pharma Financials at a Glance
Market Cap
$6.43MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$72.10K
Net Income (TTM)
-$4.84M
EPS (TTM)
-$7.46
P/E Ratio
-0.76
Dividend
$0.00
Beta (Volatility)
0.66 (Low)
Dividend
$0.00
Beta (Volatility)
0.66 (Low)
Price
$5.72
Volume
1,102
Open
$6.10
Price
$5.72
Volume
1,102
Open
$6.10
Previous Close
$5.70
Daily Range
$5.37 - $6.30
52-Week Range
$3.32 - $15.15
Estimated Earnings Date
Sep 2, 2026
Dividend
$0.00
Beta (Volatility)
0.66 (Low)
Price
$5.72
Volume
1,102
Open
$6.10
Previous Close
$5.70
Daily Range
$5.37 - $6.30
52-Week Range
$3.32 - $15.15
Estimated Earnings Date
Sep 2, 2026
SILO News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Silo Pharma
Industry
Biotechnology
Sector
Health CareEmployees
3
CEO
Eric Weisblum
Website
www.silopharma.comHeadquarters
Sarasota, FL 34236, US
SILO Financials
Key Financial Metrics (TTM)
Gross Margin
-328.69%
Operating Margin
-6631.16%
Net Income Margin
-6717.40%
Return on Equity
-88.41%
Return on Capital
-67.89%
Return on Assets
-69.01%
Earnings Yield
-1.32%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$6.43MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
1.13M
Volume
1.10K
Avg. Volume
201.92K
Financials (TTM)
Gross Profit
-$236.99K
Operating Income
-$4.78M
EBITDA
-$4.79M
Operating Cash Flow
-$3.84M
Capital Expenditure
$6.00
Free Cash Flow
-$3.84M
Cash & ST Invst.
$6.27M
Total Debt
$0.00
Silo Pharma Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$18.03K
+0.0%
Gross Profit
-$248.23K
-1598.4%
Gross Margin
-13.77%
N/A
Market Cap
$6.43MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$2.14M
N/A
Employees
3
N/A
Net Income
-$1.65M
-59.7%
EBITDA
-$1.64M
-59.9%
Quarterly Fundamentals
Total Cash
$6.27M
+15.1%
Total Debt
$0.00
N/A
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-69.01%
N/A
Return on Invested Capital
-75.73%
N/A
Free Cash Flow
-$822.62K
+49.8%
Operating Cash Flow
-$822.62K
+49.8%